Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development.

Source:http://linkedlifedata.com/resource/pubmed/id/19480547

Download in:

View as

General Info

PMID
19480547